Cross-resistance in Human Glioma Cell Lines
Author Information
Author(s): S. Merry, S.B. Kaye, R.I. Freshney
Primary Institution: Department of Clinical Oncology, University of Glasgow
Hypothesis
Is there a common mechanism underlying the emergence of resistance to various cytotoxic drugs in human glioma cell lines?
Conclusion
The study demonstrates that human glioma cell lines exhibit cross-resistance to several cytotoxic drugs, suggesting a potential common mechanism of drug resistance.
Supporting Evidence
- The study found a significant correlation between the sensitivities of the cell lines to the drugs AD, VP16, and VC.
- Cross-resistance was observed in both human glioma cell lines and animal tumor models.
- Cell lines demonstrated a wide range of sensitivity to the drugs tested, indicating variability in drug response.
Takeaway
This study looked at how certain cancer cells resist different drugs, showing that they can be resistant to multiple treatments at once.
Methodology
The study examined the in vitro sensitivity of six human glioma cell lines to various cytotoxic drugs using drug sensitivity assays.
Potential Biases
The study may not account for the heterogeneity of human tumors and the different clonal subpopulations within a single tumor.
Limitations
The results may not be representative of original tumors due to the passage number of the cultures and the complexity of clinical situations.
Participant Demographics
Cell lines were established from individual cases of malignant astrocytomas (Kernohan grade III or IV).
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website